Open Access · CC BY 3.0
GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?
Pharmacotherapy in Psychiatry and Neurology · 2026
DOI: 10.17219/fpn/241877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Marta Waliszewska-Prosół und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Waliszewska-Prosół, M., & Martelletti, P. (2026). GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/241877
Vancouver
Waliszewska-Prosół M, Martelletti P. GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/241877
BibTeX
@article{WaliszewskaPros2026,
author = {Waliszewska-Prosół, Marta and Martelletti, Paolo},
title = {GLP-1 receptor agonists and CGRP-targeted therapies in migraine: Convergent pathways or competing narratives?},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2026},
doi = {10.17219/fpn/241877}
}
EUVIMED